Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2019
Reporting Period: Third quarter ended September 30, 2019
Context: The filing announces the issuance of a press release detailing financial results for the third quarter of 2019.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in this document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the third quarter ended September 30, 2019, were announced.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It serves solely to notify the SEC of the press release issuance.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2019) for actual financial figures and operational highlights.
- Verify the company's liquidity position and cash burn rate, as these are not disclosed in the 8-K cover sheet.
- Confirm any updates to the company's strategic outlook or product pipeline mentioned in the referenced press release.
- Check for any subsequent filings that may incorporate the press release by reference.